New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global Fund to provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher. WASHINGTON, Sept. 19, 2023 /PRNewswire/... Read more
WASHINGTON, Aug. 31, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) will host a live video webcast of Veralto’s Investor and Analyst Meeting on September 6, 2023 beginning at approximately 12:00 p.m. CT. The event, which will provide a comprehensive overview of Veralto and its operating segments, will be held at Videojet’s facility in Wood Dale,... Read more
Danaher Declares pro Rata Dividend of Veralto Common Stock and Announces Expected “When-issued” Trading of Veralto Common Stock WASHINGTON, Aug. 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that it expects to complete the previously announced separation of Veralto Corporation on September 30, 2023, the first day of Danaher’s fiscal fourth quarter. The... Read more
WASHINGTON, Aug. 16, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), the global science and technology innovator, today published its 2023 Sustainability Report which conveys the depth and scope of Danaher’s sustainability program and highlights important milestones the Company achieved during the past year. “We are proud of the progress we are... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023. Second Quarter 2023 Highlights Second quarter revenue was $10.69 billion, 3% lower versus the same quarter last year. Core organic revenue growth was 2%. Second quarter GAAP... Read more
WASHINGTON, July 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the second quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended June 30, 2023 net earnings were $1.1 billion, or $1.49 per diluted common share and non-GAAP adjusted diluted net earnings per common... Read more
WASHINGTON, June 20, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2023 on Tuesday, July 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations. The... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today released its 2023 Sustainability Report, highlighting how Bruker’s spirit of ‘Innovation with Integrity’ is advancing science and technology, medicine and health, as well as safety and prosperity in a responsible, sustainable manner. The report also provides an overview of Bruker’s ESG strategy, initiatives and performance. Bruker 2023... Read more
New EVOQ DART-TQ+ system for chromatography-free triple-quadrupole mass spectrometry for point-of-need (PoN) routine analysis Launch of impact™ II VIP ESI-TOF (time of flight) system for highest sensitivity New TargetScreener™ 4D software bringing the selectivity of TIMS (trapped ion mobility spectrometry) to high-confidence analyte screening and quantitation HOUSTON–(BUSINESS WIRE)– At the 71st ASMS meeting, Bruker Corporation... Read more
ENRICH-iST enables unbiased enrichment of lower abundant plasma and serum proteins by 50% to more than 100% in human and rodent plasma proteomics in a cost-effective, fast 5-hour workflow ENRICH-iST utilizes non-functionalized paramagnetic microbeads supporting automated platforms ENRICH-iST enables protein enrichment and tryptic digestion on only 20 microL of starting material HOUSTON–(BUSINESS WIRE)– At ASMS... Read more